Relos, Dyesebel .
HRN: 26-20-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/15/2024
CEFUROXIME 750MG (VIAL)
11/15/2024
11/22/2024
IV
750mg
Q 8hrs
Dengue Fever With Warning Signs
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: No Wrong Dose
Final appropriateness: Yes
Overall appropriateness: Yes